Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Walmart will soon roll out an option that would allow consumers to pay for online orders directly via instant bank account transfers.
In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.
On Monday, BP announced it will put its US onshore wind power business, estimated to be worth about $2 billion, on the market.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Days after industrial workers in its Pacific Northwest plants voted to approve a labor strike, Boeing instituted a hiring freeze.
ispace plans to launch a second attempt to land a probe on the moon later this year, with a new record in mind.
Auction house Christie’s has agreed to buy Gooding and Company, a classic auto auction house, to expand its luxury offerings.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Moderna walked a tightrope trying to convince shareholders it can both develop a new portfolio of drugs and keep costs down in the process.
AI has a lot of promise in the healthcare industry in areas such as documentation, imaging, and quicker diagnostics as staffing shortages loom.
The Gym Group announced on Wednesday that in the first six months of this year it swung back to a profit for the first time since 2019.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.